PTGX Protagonist: Nilai bisnis marang pendapatan

Logo perusahaan publik protagonist-inc.com (PTGX)

Concentration risks in hematology for Protagonist Therapeutics (PTGX) are mitigated by alliances with global corporations. High R&D expenditures in biopharmaceuticals are replaced by superprofits following the patenting of synthesis. The advantage of a peptide pill platform over injections is visualized by the GURU.Markets portal, where the EV/Sales ratio demonstrates business resilience, and 13238.18 sets the current value of the valuation metric relative to revenue.

Protagonist Therapeutics, Inc. (PTGX): Nilai perusahaan marang pendapatan saka 23.11.2025 nganti 20.11.2026

Protagonist Therapeutics, Inc. - rincian analitis lan metrik utama (PTGX)

- data kapitalisasi saham perusahaan:
Analisis wiwitan perusahaan:PTGX, protagonist-inc.com
Produk seri Protagonist

Professional asset selection is based on finding a balance between market demand and actual revenue generation efficiency. By analyzing the company's EV/Revenue multiple, an investor assesses the Enterprise Value minus the debt load, which is critically important for Protagonist Therapeutics (PTGX) given its massive cash reserves and multi-billion dollar payments from J&J for the development of peptide drugs.

Analisis pesaing

ARGX - Multiplikator EV/Sales|BNTX: Multiplikator EV/Sales|ABVX (Abivax SA) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan ADMA Corp|Nilai perusahaan marang pendapatan Immunovant, Inc. (IMVT)|Multiplikator EV/Sales KNSA|GRFS: Nilai perusahaan marang volume dodolan|Adaptive Biotechnologies - Nilai perusahaan marang pendapatan|CLDX: Rasio nilai perusahaan marang pendapatan|Aurinia Corp - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan BioCryst Corp|VERA: Multiplikator EV/Sales|dianthustx.com (DNTH) - Multiplikator EV/Sales|PHVS (Pharvaris NV) - Multiplikator EV/Sales|ABCL: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Tourmaline Bio, Inc. (TRML)|PGEN (Intrexon) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales PHAR (Pharming Corp)|nektar.com (NKTR) - Multiplikator nilai perusahaan marang pendapatan|UPB - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ZBIO (Zenas Biopharma)|IMNM: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Gossamer Bio, Inc. (GOSS)|Rasio nilai perusahaan marang pendapatan KalVista Pharmaceuticals|Septerna Inc (SEPN) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales PVLA|SVRA (Savara) - Nilai bisnis marang pendapatan|Rigel Pharma - Nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan AnaptysBio Corp (ANAB)|ATXS: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ENGN (enGene Holdings Inc.)|RAPT Therapeutics Inc. (RAPT) - Rasio nilai perusahaan marang pendapatan|Aerovate Therapeutics Inc (JBIO) - Multiplikator EV/Sales|ACRS (Aclaris Therapeutics, Inc) - Multiplikator EV/Sales|Kyverna (KYTX) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales TLSA|Nilai perusahaan marang pendapatan Cabaletta Bio, Inc. CABA|Ventyx Biosciences - Nilai perusahaan marang pendapatan|THTX: Rasio nilai perusahaan marang pendapatan|AVTX - Rasio nilai perusahaan marang pendapatan|ELDN: Rasio nilai perusahaan marang pendapatan|Agenus Inc. (AGEN) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan Climb Bio Inc|ZURA (Zura Bio Ltd) - Multiplikator EV/Sales|Multiplikator EV/Sales aTyr Pharma Inc|Multiplikator EV/Sales ADAG|Rasio total nilai perusahaan marang pendapatan ImageneBio|Multiplikator EV/Sales STTK (Shattuck Labs Inc)|Multiplikator EV/Sales Equillium, Inc. EQ|CNTB - Rasio nilai perusahaan marang pendapatan|Immunic Therapeutics (IMUX) - Nilai perusahaan marang pendapatan|ATRA: Multiplikator EV/Sales|InflaRx GmbH (IFRX) - Multiplikator EV/Sales|XFOR (x4pharma.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Adicet Bio|Rasio nilai perusahaan marang pendapatan Celularity Inc (CELU)|Nilai perusahaan marang pendapatan INmune Bio Corp INMB|Rasio nilai perusahaan marang pendapatan Barinthus Biotherapeutics plc BRNS|KZR - Nilai perusahaan marang pendapatan|sabbiotherapeutics.com - Multiplikator EV/Sales|akaritx.com (AKTX) - Nilai perusahaan marang pendapatan|ENLV: Multiplikator EV/Sales|QTTB (Q32 Bio Inc) - Rasio nilai perusahaan marang pendapatan|GOVX (geovax.com) - Multiplikator EV/Sales|Multiplikator EV/Sales Edesa Biotech Corp|Multiplikator EV/Sales IBIO|Nilai perusahaan marang pendapatan Carisma Tx CARM|Rasio nilai perusahaan marang pendapatan XTL Biopharmaceuticals Ltd XTLB|Multiplikator EV/Sales Bolt Biotherapeutics BOLT|HCW Biologics - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan aptevotherapeutics.com|AIM (AIM ImmunoTech, Inc.) - Nilai perusahaan marang pendapatan|Aditxt Corp - Nilai bisnis marang pendapatan|GRI (GRI Bio Inc) - Multiplikator EV/Sales|Multiplikator EV/Sales XORTX Therapeutics Inc|Rasio nilai perusahaan marang pendapatan Vyome Therapeutics (HIND)|REVB - Multiplikator nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Indaptus Therapeutics, Inc. INDP|Multiplikator EV/Sales scinai.com SCNI|CalciMedica Inc - Multiplikator EV/Sales|AFMD - Multiplikator EV/Sales|ALLK: Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan HOOK (HOOKIPA Pharma, Inc.)|IGMS (IGM Biosciences) - Multiplikator EV/Sales|ITOS: Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan OCEA (Ocean Biomedical)|TCBP: Nilai perusahaan marang volume dodolan|Rasio nilai perusahaan marang pendapatan Third Harmonic Bio Inc THRD